Nu Skin(NUS) ZACKS·2025-02-10 17:05Core Viewpoint - Nu Skin Enterprises, Inc. (NUS) is expected to report a decline in both revenue and earnings for the fourth quarter of 2024, with revenue estimates at 441.1 million, which is a decrease of 9.7% from the prior-year quarter [1]. - The earnings consensus has increased by a penny to 22 cents per share, but this still represents a 40.5% decline from the year-ago quarter [2]. - NUS has a trailing four-quarter earnings surprise average of 27.3% [2]. Group 2: Factors Impacting Performance - NUS is facing a challenging operating environment characterized by inflationary pressures, political uncertainty, and weak consumer sentiment in certain markets [3]. - The direct selling industry is experiencing pressures that are likely to affect NUS's performance, compounded by adverse currency fluctuations [3]. - Despite these challenges, NUS's Rhyz business is performing well, supported by innovation, brand building, and cost management [5]. Group 3: Revenue Projections and Management Insights - NUS announced preliminary revenues for Q4 2024, stating that the figure is at the upper end of its projected range of 445 million, indicating a 9-16% decline from the previous year's reported figure [4]. - Management had previously projected adjusted earnings to be in the range of 19-29 cents per share [4]. Group 4: Earnings Prediction Model - The current model does not predict an earnings beat for NUS, as it has an Earnings ESP of +6.98% and a Zacks Rank of 5 (Strong Sell) [6].